Preclinical studies have indicated that chronic activation of GLP-1 receptors may induce dysplastic pancreatic lesions (175), but large human datasets have not shown a causal relationship between GLP-1 RAs and pancreatic cancer (173, 176). This evidence concerns the gene GLP1R and pancreatic neoplasm.